New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export BMY’s income statement to Excel — free account
Bristol Myers Squibb Company
BMYHealthcare Drug Manufacturers General
Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.
- Revenue
- +6.93%
- EPS
- −2.78%
- Free cash flow
- −36.0%
- Total debt
- −12.5%
Quarter to September 2026, against a year earlier
59.43
1.09
+1.87%
Follow BMY
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow of $12.8B covered $5.0B of dividends and buybacks. Cash fell by $129.0M. What is a cash flow statement?
- Free cash flow
- $12.8B 90.7% of operating cash flow
- Returned to shareholders
- $5.0B 39.3% of free cash flow
- Debt, net
- −$5.2B repaid
- Change in cash
- −$129.0M over the period
| Operating cash flow | 14.2 |
|---|---|
| Capital expenditures | −1.3 |
| Free cash flow | 12.8 |
| Acquisitions, net | −2.9 |
| From investments, net | +0.1 |
| Dividends | −5.0 |
| Debt repaid, net | −5.2 |
| Other | +0.1 |
| Change in cash | −0.1 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.1B | $5.3B | $7.1B | $8.2B | $14.1B | $16.2B | $13.1B | $13.9B | $15.2B | $14.2B |
| Capex | −$1.2B | −$1.1B | −$951M | −$836M | −$753M | −$973M | −$1.1B | −$1.2B | −$1.2B | −$1.3B |
| Free cash flow | $1.8B | $4.2B | $6.1B | $7.4B | $13.3B | $15.2B | $11.9B | $12.7B | $13.9B | $12.8B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
4,507.00 | 975.00 | 4,947.00 | 3,460.00 | (8,995.00) | 7,014.00 | 6,345.00 | 8,040.00 | (8,933.00) | 7,055.00 |
Depreciation & Amortization |
382.00 | 789.00 | 637.00 | 1,746.00 | 10,380.00 | 10,686.00 | 10,276.00 | 9,760.00 | 9,600.00 | 4,011.00 |
Non Cash Items (Other) |
(643.00) | 1,246.00 | 1,265.00 | (140.00) | 11,680.00 | (232.00) | (1,326.00) | (2,026.00) | 13,713.00 | 3,545.00 |
Accounts Receivable Change |
(803.00) | (431.00) | (429.00) | 752.00 | (646.00) | (1,054.00) | (663.00) | (995.00) | 264.00 | (295.00) |
Change in inventories |
(152.00) | (29.00) | (216.00) | 463.00 | 2,672.00 | 13.00 | (69.00) | (751.00) | (486.00) | (184.00) |
Change in payables and accrued liability |
104.00 | 320.00 | (59.00) | 229.00 | 188.00 | 245.00 | 109.00 | 198.00 | 184.00 | (2.00) |
Income tax paid |
(453.00) | 3,154.00 | 203.00 | 907.00 | (2,305.00) | (1,063.00) | (1,423.00) | (603.00) | (1,260.00) | (4.00) |
Change in other assets and liabilities |
152.00 | (869.00) | 718.00 | 819.00 | 1,078.00 | 598.00 | (183.00) | 237.00 | 2,108.00 | 30.00 |
Other operating activities |
(36.00) | 120.00 | (44.00) | (26.00) | (177.00) | 142.00 | — | — | — | — |
Operating Cash Flow |
3,058.00 | 5,275.00 | 7,066.00 | 8,210.00 | 14,052.00 | 16,207.00 | 13,066.00 | 13,860.00 | 15,190.00 | 14,156.00 |
Capital expenditures |
(1,215.00) | (1,055.00) | (951.00) | (836.00) | (753.00) | (973.00) | (1,118.00) | (1,209.00) | (1,248.00) | (1,311.00) |
Net Aquisitions |
975.00 | 10.00 | (1,123.00) | (9,092.00) | (12,343.00) | (862.00) | (2,981.00) | (260.00) | (20,722.00) | (2,873.00) |
Short Term Investments Change (Net) |
1,720.00 | 979.00 | 74.00 | (152.00) | 2,108.00 | (1,282.00) | 2,819.00 | (1,041.00) | 353.00 | (25.00) |
Long-Term Investments Change (Net) |
— | — | — | 167.00 | 129.00 | 2,579.00 | 218.00 | 215.00 | 265.00 | 77.00 |
Investing cash flow |
1,480.00 | (66.00) | (2,000.00) | (9,913.00) | (10,859.00) | (538.00) | (1,062.00) | (2,295.00) | (21,352.00) | (4,132.00) |
Repayment/Issuance of Debt (Net) |
110.00 | 991.00 | (548.00) | 17,653.00 | 3,928.00 | (6,182.00) | (5,311.00) | 456.00 | 10,096.00 | (5,175.00) |
Equity Repurchase (Common, Net) |
(231.00) | (2,469.00) | (320.00) | (7,300.00) | (1,546.00) | (6,287.00) | (8,001.00) | (5,155.00) | — | — |
Dividends Paid (Total) |
(2,547.00) | (2,577.00) | (2,613.00) | (2,679.00) | (4,075.00) | (4,396.00) | (4,634.00) | (4,744.00) | (4,863.00) | (5,045.00) |
Other financial activities |
15.00 | (22.00) | (54.00) | (53.00) | 542.00 | 641.00 | 984.00 | 27.00 | (106.00) | (128.00) |
Financing cash flow |
(2,653.00) | (4,077.00) | (3,535.00) | 7,621.00 | (1,151.00) | (16,224.00) | (16,962.00) | (9,416.00) | 5,127.00 | (10,348.00) |
Exchange Rate Adjustment |
(33.00) | 52.00 | (41.00) | (9.00) | 111.00 | (102.00) | (33.00) | 45.00 | (137.00) | 195.00 |
Change in Cash |
1,852.00 | 1,184.00 | 1,490.00 | 5,909.00 | 2,153.00 | (657.00) | (4,991.00) | 2,194.00 | (1,172.00) | (129.00) |
Beginning Cash |
2,385.00 | 4,237.00 | 5,421.00 | 6,911.00 | 12,820.00 | 14,973.00 | 14,316.00 | 9,325.00 | 11,519.00 | 10,347.00 |
Ending Cash |
4,237.00 | 5,421.00 | 6,911.00 | 12,820.00 | 14,973.00 | 14,316.00 | 9,325.00 | 11,519.00 | 10,347.00 | 10,218.00 |
Stock Based Compensation |
205.00 | 199.00 | 221.00 | 441.00 | 779.00 | 583.00 | 457.00 | 518.00 | 507.00 | 553.00 |
Dividends Paid (Common) |
(2,547.00) | (2,577.00) | (2,613.00) | (2,679.00) | (4,075.00) | (4,396.00) | (4,634.00) | (4,744.00) | (4,863.00) | (5,045.00) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(1,152.00) | 2,145.00 | 217.00 | 3,170.00 | 987.00 | (1,261.00) | (2,229.00) | (1,914.00) | 810.00 | (455.00) |
Investments Change (Net) |
1,720.00 | 979.00 | 74.00 | 15.00 | 2,237.00 | 1,297.00 | 3,037.00 | (826.00) | 618.00 | 52.00 |
Issuance/Purchase of Shares |
(231.00) | (2,469.00) | (320.00) | (7,300.00) | (1,546.00) | (6,287.00) | (8,001.00) | (5,155.00) | — | — |
| Other line items | ||||||||||
Revenue per Employee |
0.78 | 0.88 | 0.97 | 0.87 | 1.41 | 1.44 | 1.35 | 1.32 | 1.42 | 1.48 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026